Skip to main content
LNSR
NASDAQ Life Sciences

LENSAR Posts Robust Q1: $36.3M Net Income, $37.3M EBITDA

feedReported by Reuters
Sentiment info
Positive
Importance info
9
Price
$5.23
Mkt Cap
$63.306M
52W Low
$5.06
52W High
$14.31
Market data snapshot near publication time

summarizeSummary

LENSAR, Inc. announced exceptionally strong first-quarter results, reporting a net income of $36.3 million and EBITDA of $37.3 million. These figures represent a significant portion of the company's current market capitalization, indicating a highly profitable quarter. This new financial data is critical for traders, as it was not included in the recent 10-K/A filing and could lead to a substantial positive re-evaluation of the stock, particularly given its proximity to a 52-week low. Investors will now closely monitor the upcoming 10-Q filing for detailed financial statements and management's outlook on the sustainability of this performance.

At the time of this announcement, LNSR was trading at $5.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $63.3M. The 52-week trading range was $5.06 to $14.31. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed LNSR - Latest Insights

LNSR
May 08, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
LNSR
May 08, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
LNSR
May 08, 2026, 7:00 AM EDT
Source: Reuters
Importance Score:
9
LNSR
Apr 15, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
LNSR
Mar 31, 2026, 4:14 PM EDT
Filing Type: 10-K
Importance Score:
8
LNSR
Mar 31, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
9
LNSR
Mar 31, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
7
LNSR
Mar 17, 2026, 8:26 AM EDT
Filing Type: 8-K
Importance Score:
8
LNSR
Mar 16, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
9
LNSR
Mar 13, 2026, 6:02 AM EDT
Filing Type: 8-K/A
Importance Score:
8